Put your knowledge of male infertility diagnosis and treatment strategies to the test with Dr. Alexander Pastuszak, an Assistant Professor at the University of Utah School of Medicine, as he breaks down its common causes and how we can improve care for our male patients.
Even though hypogonadism is common among men, there are still some misconceptions surrounding it. So to learn more about how we can better diagnose and treat hypogonadism in our male patients, Dr. Paul Doghramji sits down with Dr. Alexander Pastuszak, an Assistant Professor at the University of Utah School of Medicine.
While at the ReachMD Innovation Theater in Chicago, Founder and Director Emeritus of the Columbus Center for Women’s Health Research Dr. David Portman provided us with his perspective on using PRP injections and alprostadil topically for patients with anorgasmia.
For the one in eight women who will develop breast cancer in their lifetime and for the three million breast cancer survivors, what’s the best way to manage genitourinary syndrome of menopause (GSM)? Founder and Director Emeritus of the Columbus Center for Women’s Health Research Dr. David Portman explains the rationale behind his approach.
Recorded live during ReachMD's Innovation Theater in Chicago, Illinois, Founder and Director Emeritus of the Columbus Center for Women’s Health Research Dr. David Portman joins Dr. Matt Birnholz to share his tips for getting past the taboo and providing sexual health counseling and treatment to your patients.
From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Robert Frankel talks with Dr. Neilanjan Nandi, Assistant Professor in the Division of Gastroenterology & Hepatology and Associate Director of the Gastroenterology Fellowship program at Drexel University College of Medicine. Dr. Nandi shares new insights on how to approach sexual and intimacy issues for IBD patients. Discussion points include quality of life measures, methods for maintaining healthy intimate relationships, respecting boundaries, and top health practitioner resources.
Feminine hygiene, though an important part of daily life, is rarely discussed openly,not even in clinical settings.
Host Dr. Michael Krychman sits down with Dr Alyssa Dweck, practicing gynecologist in New York and Assistant Clinical Professor at Mt. Sinai School of Medicine. They give essential tips for clinicians on how to talk to patients about feminine hygiene.
The primary purpose of contraception is to separate sex from procreation. However, sexual function is rarely addressed or considered in the context of making contraceptive choices.
Dr. Michael Krychman speaks with Dr. Rachel Perry, Assistant Professor of OB/GYN at the University of California-Irvine, about the various complex sexual health impacts of oral contraceptives, IUDs, condoms, and permanent sterilization procedures.
Dr. Michael Krychman welcomes Mary Jo Rapini, a psychotherapist specializing in intimacy, sex and relationships who maintains a private practice in Houston, TX. Ms. Rapini co-authored RE-COUPLING: A Couple’s 4-step Guide to Greater Intimacy and Better Sex.
Flibanserin was one of the first FDA-approved medications for treatment of Hypoactive Sexual Desire Disorder in pre-menopausal women. But the drug's effectiveness has frequently been called into question, and the known side effects such as fainting, dizziness, and low blood pressure, many of which were found to be exacerbated by alcohol and hormonal contraception, created concerns for clinicians and patients alike.
Host Dr. Michael Krychman talks with guest Dr. Lisa Larkin, women’s health internist and Director of the Women's Health Center at the University of Cincinnati College of Medicine, about the “Pink Viagra" pill, concerns around its safety and effectiveness, and the diagnosis and treatment of HDSS.
Ovarian cancer is among the most highly prevalent and deadly cancers in existence, and in the struggle to care for patients and protect their quality of life, clinical standards in diagnostic screening and treatment protocols must change frequently.
Joining host Dr. Michael Krychman to discuss advances in treatment and prevention of ovarian cancer, with special focus on sexual health priorities, is guest Dr. Leslie Randall. Dr. Randall is Associate Professor of Obstetrics and Gynecology at the University of California-Irvine, and also Director of UC’s gynecologic oncology fellowship program.
There are many herbs and supplements that have gained popularity as natural sexual aphrodisiacs. While many are sold over the counter nationwide to enhance sexual function, a surprising number of supplements can cause ranges of serious side effects. Which aphrodisiacs have been proven effective, which are safe, and which are potentially deadly?
Host Dr. Michael Krychman joins Dr. Elizabeth West, a resident physician at the University of California-Irvine, to talk about the spectrum of natural herbs and supplements, from foods like honey and chocolate to herbs such as ginseng and macca, and their known sexual health benefits vs risks.
Clinicians play an important role in helping patients understand and navigate issues around the use of sexual accessories to help improve sexual health for both men and women. With expertise in underlying issues such as vaginal dryness and discomfort with sex, health experts can better advise patients on which products to seek versus avoid.
Host Dr. Michael Krychman joins guest Dr. Barb DePree, gynecologist and Director of Midlife Woman’s Health at Holland Hospital, to discuss ways physicians can talk about accessories to advance sexual health for patients.
Women who experience low libido often feel embarrassed, lonely, and unsure where to turn or with whom to confide. Left unaddressed, this issue can have devastating effects on relationships.
Dr. Michael Krychman sits down with Amanda Parrish, nationally recognized patient advocate for women's sexual health, to talk about hypoactive sexual desire disorder (HSDD) and the need for clinicians to foster open conversations with patients about low libido.
Monogamous relationships are firmly embedded in the framework of our society, and yet the divorce rate and common failures of intimacy in long-term relationships challenges the efficacy of this paradigm. Oddly, the concept of monogamy has been virtually ignored by health professionals. Why are issues in sexual relationships getting the silent treatment in healthcare, and what can be done to curb this trend?
Dr. Michael Krychman welcomes guest Dr. Marianne Brandon, clinical sexologist and acclaimed author of Monogomy: The Untold Story. Dr. Brandon offers a clinical psychologist's and sex therapist's insights and solutions to the challenges of monogamous relationships.
Dr. Michael Krychman interviews Dr. Brett Worly, Assistant Professor of Obstetrics and Gynecology at the Ohio State University School of Medicine. Dr. Worly talks about successful integrations of sexual medicine into evaluative, diagnostic, and treatment protocols in women's health practice, and how this progression led to the formation of a novel women's sexual health clinic at OSU.
Host Dr. Michael Krychman welcomes Dr. Risa Kagan to discuss the intimacy and sexuality issues that patients face when they are dealing with fragility fractures. Dr. Kagan is Clinical Professor of Obstetrics, Gynecology, and Reproductive Sciences at the University of California, San Francisco. Since October 2005, she has been practicing gynecology with the East Bay Physicians Medical Group. Dr. Kagan is also a medical consultant at the Foundation for Osteoporosis Research and Education (FORE), and principal investigator on several clinical research trials involving women’s health. She is a North American Menopause Society (NAMS) certified Menopause Practitioner and is certified by the International Society of Clinical Densitometry.
Flibanserin's approval by the FDA for women with hypoactive sexual desire disorder (HSDD), touted by the press as the "Pink Viagra," created an enormous amount of media hype across the nation. But the facts on this drug's mechanism of action, intended benefits, adverse effects, and efficacy borne in clinical trials have gone largely under the radar.
Joining Dr. Michael Krychman to discuss the rise of flibanserin and its key takeaways for clinicians is Dr. Sheryl Kingsberg, Chief of the Division of Behavioral Medicine in the Department of OB/GYN and Professor in the Departments of Reproductive Biology and Psychiatry at Case Medical Center University Hospitals in Cleveland, Ohio.
As many clinicians have become increasingly aware, the problem of obesity involves a complex interplay of habits and hormones, influenced by genetic predispositions and cultural practices alike. Whereas the supposed magic bullets of weight loss pills and fad diets are always in high demand, few to none have demonstrated consistent benefit for patients, and the struggle to avoid the "yo yo effect" of regained weight goes on.
Sexual health problems represent some of the most difficult issues reported by patients who are obese, but rarely are these complaints properly registered or addressed by clinicians. Joining Dr. Michael Krychman at ACOG’s annual scientific meeting to focus on this neglected aspect of obesity is Dr. Maida Taylor, Clinical Professor of OB/GYN and Reproductive Sciences of the University of California-San Francisco. They discuss counseling strategies and interventions for patients striving toward better sexual health as they pursue more healthy, stable weight.
Low libido, a condition affecting an estimated 10% of women, can develop at any age and be attributed to several factors in a woman’s life, from lifestyle changes to medication and procedural side effects.
Join host Dr. Michael Krychman and Dr. Leah Millheiser, Director of Female Sexual Medicine at Stanford University School of Medicine, on the floor of ACOG’s annual scientific meeting. They discuss current knowledge gaps in recognizing and treating low libido, and the importance of sexual health psychology within therapeutic approaches.